skills/deal-process-tracker/references/md-judgment.md

# MD Judgment Framework

Use this reference to turn process facts into senior-banker judgment. The goal is not to sound busy; it is to tell the deal team what matters, where momentum is changing, and what action preserves value and optionality.

## Table of Contents

- [Process health rating](#process-health-rating)
- [Buyer credibility framework](#buyer-credibility-framework)
- [Buyer-type nuances](#buyer-type-nuances)
- [Competitive tension assessment](#competitive-tension-assessment)
- [NDA and access judgment](#nda-and-access-judgment)
- [Diligence judgment](#diligence-judgment)
- [Bid and round-decision judgment](#bid-and-round-decision-judgment)
- [Escalation logic](#escalation-logic)
- [Client-management judgment](#client-management-judgment)
- [Process-specific red flags](#process-specific-red-flags)

## Process health rating

Use a simple process health status and explain the reason.

| rating | meaning | typical readout |
|---|---|---|
| green | process is on track with enough credible buyer activity and manageable issues | maintain cadence; no unusual intervention |
| yellow | manageable issues but watch momentum, deadlines, or bottlenecks | targeted follow-up and workstream discipline needed |
| orange | meaningful risk to timing, tension, value, or certainty | MD/client/counsel intervention likely needed |
| red | process is off track or key transaction objective is at risk | senior escalation and revised strategy required |

Consider the rating across: credible buyer count, buyer mix, NDA/CIM conversion, diligence backlog, bid deadline readiness, client responsiveness, legal bottlenecks, confidentiality exposure, financing/regulatory risk, and competitive tension.

## Buyer credibility framework

Evaluate buyer credibility by behavior rather than self-described interest.

### Strong signals

- Senior decision-makers are engaged: CEO, CFO, business-unit president, Head of CorpDev, deal partner, IC member.
- NDA turnaround is fast and redlines are reasonable.
- Buyer articulates a specific acquisition rationale, synergy thesis, platform angle, or portfolio-company fit.
- Diligence questions are specific, sequenced, and tied to valuation or closing certainty.
- Buyer adds advisors, financing sources, operating executives, or functional diligence leads.
- Buyer attends management meetings with senior people and asks bid-relevant questions.
- Buyer asks process-letter, bid mechanics, financing, regulatory, or confirmatory diligence questions.
- Buyer references timing to IC/board approval or a concrete internal decision path.

### Weak signals

- Generic interest with no clear rationale.
- Slow NDA execution with little business follow-up.
- Junior-only attendance.
- No data-room activity after CIM access.
- Repeated rescheduling or deadline extension requests.
- Broad information requests before price indication.
- Focus on market education rather than acquisition rationale.
- Avoids bid timing, financing, or approvals discussion.
- Requests sensitive competitor information prematurely.

### Buyer labels

Use these labels when useful:

- **high-conviction bidder**: credible process behavior and likely actionable bid.
- **credible but unresolved**: engaged, but one or two gating issues remain.
- **price tension only**: useful to maintain competition but unlikely best buyer.
- **strategic option value**: potentially valuable, but slow or conditional.
- **process tourist**: appears to be learning or monitoring rather than bidding.
- **likely no-bid**: behavior suggests low probability, but not confirmed pass.
- **needs senior call**: relationship or momentum requires MD/partner intervention.

## Buyer-type nuances

### Strategic buyers

Strategics can create the highest value but often bring confidentiality, speed, and regulatory risk. Track business-unit sponsor, CorpDev lead, internal approvals, synergy thesis, competitor sensitivity, clean-team needs, regulatory overlap, and CEO/CFO access.

MD instincts:

- A slow strategic may still be valuable if the CEO/CFO or CorpDev head is engaged.
- A competitor asking for customer, pricing, or product-level detail before bid intent is a confidentiality risk.
- A strategic with regulatory overlap may set price tension but require risk-adjustment versus a cleaner sponsor bid.

### Financial sponsors

Sponsors are disciplined and financing-driven. Track deal partner, operating partner, IC timing, debt financing, platform/add-on angle, advisor activity, leverage assumptions, valuation sensitivity, and history of retrading.

MD instincts:

- Sponsor interest without financing work is not the same as a credible final bid.
- Sponsors may ask broad diligence to shape price; distinguish legitimate confirmatory asks from fishing.
- A slightly lower sponsor bid may be superior if financing is committed and documentation path is clean.

### Sponsor portfolio companies

These blur strategic and sponsor dynamics. Track sponsor owner, portfolio-company management, synergy thesis, financing source, integration burden, and which party is really driving the deal.

### Public-company sale / take-private

Add governance and process fairness sensitivity: board/special committee timeline, MNPI controls, standstill, disclosure constraints, shareholder vote, regulatory approvals, leak response, and fairness opinion process. Flag counsel review for inconsistent access, deadline extensions, or disclosure issues.

### Carve-out

Emphasize perimeter, standalone financials, stranded costs, TSAs, systems separation, employee transfer, contract assignment, tax, working capital, and parent approvals. Diligence bottlenecks often reflect seller readiness, not buyer weakness.

### Distressed / special situations

Emphasize speed and certainty: liquidity runway, forbearance, bankruptcy court milestones, stalking horse, qualified bid requirements, deposits, proof of funds, creditor approvals, and closing certainty.

### Cross-border

Track time zones, local counsel, foreign investment approvals, sanctions/restricted parties, labor consultation, data privacy, tax/FX, translations, and local regulatory filings.

## Competitive tension assessment

Ask:

1. How many credible bidders remain?
2. Are strategics and sponsors moving on compatible timelines?
3. Is one buyer too far ahead, creating early exclusivity pressure?
4. Are backup bidders warm enough to preserve leverage?
5. Are buyers receiving consistent information and deadline treatment?
6. Are deadline extensions preserving value or undermining process credibility?
7. Is the process too broad, creating leak risk, or too narrow, reducing value discovery?

Default conclusions:

- **strong tension**: multiple credible bidders with comparable access and deadlines.
- **adequate but fragile**: enough bidders remain, but one or two gating issues could reduce leverage.
- **weakening**: few credible bidders, stale outreach, or uneven stage progression.
- **single-bidder risk**: one buyer is effectively driving the process; keep backups warm or revisit buyer universe.

## NDA and access judgment

Do not treat NDA status as administrative only. NDA friction affects process timing and buyer quality.

Benign legal delay indicators:

- Business contact remains engaged.
- Legal contact is active.
- Redlines are narrow and standard.
- Buyer has provided target review timing.

Interest-risk indicators:

- No legal contact after initial interest.
- Buyer does not respond to business follow-up.
- NDA sits for several business days without explanation.
- Buyer asks for materials before signing but avoids process commitment.

Access principles:

- No CIM or data-room access before NDA execution unless user gives explicit instruction and counsel/access rules allow it.
- Competitors require heightened review for customer, pricing, product, employee, contract, and technology materials.
- Clean-team restrictions should be tracked at buyer and document-folder level.
- Public-company/MNPI issues require human/counsel review.

## Diligence judgment

Classify requests by process implication:

- **routine confirmatory**: normal and should be answered quickly.
- **value-relevant**: may affect price or structure.
- **certainty-relevant**: may affect ability to sign/close.
- **timing-relevant**: may delay bid or signing.
- **fishing/overreaching**: premature or too broad, especially for competitors.
- **red-flag**: suggests buyer identified a material concern.
- **process-leverage**: may become basis for re-trade or conditionality.

Look for repeated themes across buyers. If multiple buyers ask the same question, elevate it from a buyer-specific item to a process-wide issue.

Example judgment:

"Revenue durability is becoming a process-wide issue: three buyers asked for retention/cohort detail within 48 hours. Prepare a seller-approved response package before IOIs rather than answering ad hoc."

## Bid and round-decision judgment

Never rank bids by headline value alone. Compare:

- headline enterprise/equity value
- structure: cash, stock, rollover, earnout, contingent value
- working capital/cash/debt assumptions
- financing certainty
- regulatory and approval risk
- diligence conditionality
- documentation complexity
- time to sign and close
- buyer reputation and retrade history
- ability to improve
- fit with seller/client priorities

Recommended labels:

- **lead bid**: best risk-adjusted path.
- **value-maximizing but risky**: high price but uncertain close.
- **certainty anchor**: lower price but cleaner execution.
- **price tension bid**: useful negotiating leverage but unlikely winner.
- **backup bid**: credible fallback.
- **not actionable**: too conditional, vague, unfunded, or incomplete.

## Escalation logic

Escalate to MD/partner when:

- High-priority buyer is stalled or cooling.
- Strategic buyer has NDA/legal friction affecting CIM access.
- Sponsor needs financing clarity before bid deadline.
- Buyer requests extension near bid deadline.
- Buyer asks for sensitive or restricted materials.
- Client delays critical diligence responses.
- Counsel is slowing process-letter/NDA turnaround.
- Competitive tension is weakening.
- Bidder may be retrading.
- Public-company/board/fairness process issue appears.

Make recommendations specific:

- weak: "follow up with Buyer A"
- strong: "MD to call Buyer A's Head of CorpDev today to confirm bid intent before granting incremental customer-level diligence"

## Client-management judgment

Track client obligations as aggressively as buyer obligations. Common client-side bottlenecks:

- delayed financial updates
- unapproved diligence responses
- unclear customer-data sharing rules
- management availability
- counsel review delays
- unfinalized process letter
- board/sponsor approval timing
- internal disagreement on price expectations

Client-safe language should be controlled:

- internal: "Buyer B appears to be using diligence to pressure price."
- client-safe: "Buyer B has requested incremental diligence and may require additional support to maintain bid timing and valuation."

## Process-specific red flags

- "active" buyer with no touchpoint in more than five business days during a live auction.
- NDA executed but no CIM/data-room activity after several business days.
- CIM sent before NDA/access approval is documented.
- Bid deadline approaching with unanswered value-relevant diligence.
- Buyer asks for extension without explicit bid intent.
- One buyer receives materially different information without documented rationale.
- High headline bid has no financing, broad conditionality, or unclear approvals.
- Exclusivity granted without warm backup bidders.
- Public-company process lacks counsel/governance review for access/deadline differences.